Page 1 of 38
2025/2026 CMN 548 MODULE 5
PSYCHOPHARMACOLOGY EXAM COMPLETE
CURRENT TESTING QUESTION AND DETAILED
CORRECT (VERIFIED) ANSWER/GURANTEED
PASS/TOP-RATED A+.
CMN 548
Ace your CMN 548 Module 5 Psychopharmacology exam with
this targeted guide, designed to master neurotransmitter
systems, psychotropic medications, and treatment protocols for
mental health disorders. This resource delivers scenario-based
practice questions evidence-based covering mechanisms of
action, side effect management, and patient monitoring.
Which patient populations are at highest risk for tardive
dyskinesia? ...... ANSWER ....... - Older women
- Patients with affective disorders
- 10-20% incidence in treatment >1 year
How often should patients receiving dopamine blockers be
evaluated for tardive dyskinesia? ...... ANSWER .......
Every 6 months
, Page 2 of 38
- Can evaluate severity using the Abnormal Involuntary
Movements Scale (AIMS)
Why does clozapine (Clozaril, DSA antipsychotic) have a
lower risk of tardive dyskinesia? ...... ANSWER ....... It
does not result in the increased sensitivity of striatal D2
receptors, which is associated with typical neuroleptics
and has been theorized to result in TD.
What is the mechanism of action of the two medications
approved for treatment of Tardive Dyskinesia? ......
ANSWER ....... VMAT2 inhibitors
- Can be given in conjunction with antipsychotics
What medication is contraindicaated in the treatment of
antipsychotic induced hypotension? ...... ANSWER .......
Epinephrine
- due to beta stimulation it worsens hypotension
What is the only dopamine serotonin antagonist (DSA) that is
more effective than other antipsychotics at improving overall
symptoms? ...... ANSWER ....... Clozapine (Clozaril)
, Page 3 of 38
- This is why antipsychotics are typically chosen based on
side effect profile
Olanzapine (Zyprexa, DSA antipsychotic) causes what side
effects in children? ...... ANSWER ....... - Somnolence
- Liver enzyme elevation
- Prolactin elevation
- Weight gain
*Due to these effects it should be used only when other
antipsychotics have failed
Olanzipine (Zyprexa, DSA antipsychotic) has what effect of
liver enzymes? ...... ANSWER ....... Increases ALT to 3
times the upper limit of normal in 2% of cases
Which medication in the DSA antipsychotic family has a low
liability for metabolic side effects? ...... ANSWER .......
Lurasidone (Latuda)
- take with food
- potent antagonist at 5-HT2A, D2, and 5-HT7 receptors
and a partial agonist at the 5-HT1A receptor.
, Page 4 of 38
- Side effects include sedation, EPS, nausea
Lurasidone (Latuda, DSA antipsychotic) is FDA approved for
the treatment of what? ...... ANSWER ....... -
Schizophrenia in adults
- Adults with bipolar depression as a monotherapy or
adjunct to lithium or valproate
Which DSA antipsychotic does not cause EPS, but is
associated with significant hematologic toxicity? ......
ANSWER ....... Clozapine (Clozaril)
- Agranulocytosis
- Reversible when drug is stopped
- Propranolol increases risk of agranulocytosis
Clozapine (Clozaril) is indicated for patients with which
psychiatric diagnosis who are treatment resistant or unable
to tolerate side effects? ...... ANSWER .......
Schizophrenia
- Clozapine (Clozaril, DSA antipsychotic)
- Minimal EPS side effects or tardive dyskinesia
2025/2026 CMN 548 MODULE 5
PSYCHOPHARMACOLOGY EXAM COMPLETE
CURRENT TESTING QUESTION AND DETAILED
CORRECT (VERIFIED) ANSWER/GURANTEED
PASS/TOP-RATED A+.
CMN 548
Ace your CMN 548 Module 5 Psychopharmacology exam with
this targeted guide, designed to master neurotransmitter
systems, psychotropic medications, and treatment protocols for
mental health disorders. This resource delivers scenario-based
practice questions evidence-based covering mechanisms of
action, side effect management, and patient monitoring.
Which patient populations are at highest risk for tardive
dyskinesia? ...... ANSWER ....... - Older women
- Patients with affective disorders
- 10-20% incidence in treatment >1 year
How often should patients receiving dopamine blockers be
evaluated for tardive dyskinesia? ...... ANSWER .......
Every 6 months
, Page 2 of 38
- Can evaluate severity using the Abnormal Involuntary
Movements Scale (AIMS)
Why does clozapine (Clozaril, DSA antipsychotic) have a
lower risk of tardive dyskinesia? ...... ANSWER ....... It
does not result in the increased sensitivity of striatal D2
receptors, which is associated with typical neuroleptics
and has been theorized to result in TD.
What is the mechanism of action of the two medications
approved for treatment of Tardive Dyskinesia? ......
ANSWER ....... VMAT2 inhibitors
- Can be given in conjunction with antipsychotics
What medication is contraindicaated in the treatment of
antipsychotic induced hypotension? ...... ANSWER .......
Epinephrine
- due to beta stimulation it worsens hypotension
What is the only dopamine serotonin antagonist (DSA) that is
more effective than other antipsychotics at improving overall
symptoms? ...... ANSWER ....... Clozapine (Clozaril)
, Page 3 of 38
- This is why antipsychotics are typically chosen based on
side effect profile
Olanzapine (Zyprexa, DSA antipsychotic) causes what side
effects in children? ...... ANSWER ....... - Somnolence
- Liver enzyme elevation
- Prolactin elevation
- Weight gain
*Due to these effects it should be used only when other
antipsychotics have failed
Olanzipine (Zyprexa, DSA antipsychotic) has what effect of
liver enzymes? ...... ANSWER ....... Increases ALT to 3
times the upper limit of normal in 2% of cases
Which medication in the DSA antipsychotic family has a low
liability for metabolic side effects? ...... ANSWER .......
Lurasidone (Latuda)
- take with food
- potent antagonist at 5-HT2A, D2, and 5-HT7 receptors
and a partial agonist at the 5-HT1A receptor.
, Page 4 of 38
- Side effects include sedation, EPS, nausea
Lurasidone (Latuda, DSA antipsychotic) is FDA approved for
the treatment of what? ...... ANSWER ....... -
Schizophrenia in adults
- Adults with bipolar depression as a monotherapy or
adjunct to lithium or valproate
Which DSA antipsychotic does not cause EPS, but is
associated with significant hematologic toxicity? ......
ANSWER ....... Clozapine (Clozaril)
- Agranulocytosis
- Reversible when drug is stopped
- Propranolol increases risk of agranulocytosis
Clozapine (Clozaril) is indicated for patients with which
psychiatric diagnosis who are treatment resistant or unable
to tolerate side effects? ...... ANSWER .......
Schizophrenia
- Clozapine (Clozaril, DSA antipsychotic)
- Minimal EPS side effects or tardive dyskinesia
